nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—ABHD16A—parotid gland—salivary gland cancer	0.0449	0.103	CbGeAlD
Orlistat—ABHD16A—saliva-secreting gland—salivary gland cancer	0.043	0.099	CbGeAlD
Orlistat—PLA2G7—connective tissue—salivary gland cancer	0.0421	0.0969	CbGeAlD
Orlistat—ABHD12—parotid gland—salivary gland cancer	0.0421	0.0968	CbGeAlD
Orlistat—ABHD12—saliva-secreting gland—salivary gland cancer	0.0403	0.0927	CbGeAlD
Orlistat—PNLIP—connective tissue—salivary gland cancer	0.037	0.0852	CbGeAlD
Orlistat—FASN—saliva-secreting gland—salivary gland cancer	0.0338	0.0778	CbGeAlD
Orlistat—PLA2G7—lymphoid tissue—salivary gland cancer	0.0308	0.0708	CbGeAlD
Orlistat—DAGLB—lymph node—salivary gland cancer	0.0215	0.0495	CbGeAlD
Orlistat—PLA2G7—lymph node—salivary gland cancer	0.0174	0.04	CbGeAlD
Orlistat—ABHD16A—lymph node—salivary gland cancer	0.0163	0.0375	CbGeAlD
Orlistat—PLA2G4A—saliva-secreting gland—salivary gland cancer	0.0163	0.0374	CbGeAlD
Orlistat—ABHD12—lymph node—salivary gland cancer	0.0153	0.0351	CbGeAlD
Orlistat—PLA2G4A—connective tissue—salivary gland cancer	0.0149	0.0344	CbGeAlD
Orlistat—FASN—lymph node—salivary gland cancer	0.0128	0.0295	CbGeAlD
Orlistat—PLA2G4A—lymph node—salivary gland cancer	0.00616	0.0142	CbGeAlD
Orlistat—PNLIP—Disease—MAML3—salivary gland cancer	0.00238	0.0042	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MARCKS—salivary gland cancer	0.00234	0.00414	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—WNT5B—salivary gland cancer	0.00227	0.00402	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—WNT5B—salivary gland cancer	0.00227	0.00402	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL17RD—salivary gland cancer	0.00219	0.00388	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL17RD—salivary gland cancer	0.00219	0.00388	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PYGB—salivary gland cancer	0.00218	0.00385	CbGpPWpGaD
Orlistat—FASN—SREBP signalling—PIK3CA—salivary gland cancer	0.00206	0.00365	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—PIK3CA—salivary gland cancer	0.00206	0.00365	CbGpPWpGaD
Orlistat—PNLIP—Disease—ST3GAL4—salivary gland cancer	0.00204	0.0036	CbGpPWpGaD
Orlistat—FASN—Metabolism—ISYNA1—salivary gland cancer	0.00203	0.00359	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAML3—salivary gland cancer	0.00201	0.00355	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAML3—salivary gland cancer	0.00201	0.00355	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—TP53—salivary gland cancer	0.002	0.00353	CbGpPWpGaD
Orlistat—FASN—Disease—WNT5B—salivary gland cancer	0.0019	0.00336	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.0019	0.00336	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—WNT5B—salivary gland cancer	0.00188	0.00333	CbGpPWpGaD
Orlistat—PNLIP—Disease—DTX4—salivary gland cancer	0.00185	0.00327	CbGpPWpGaD
Orlistat—FASN—Disease—CPSF4—salivary gland cancer	0.00184	0.00325	CbGpPWpGaD
Orlistat—FASN—Disease—PYGB—salivary gland cancer	0.00184	0.00325	CbGpPWpGaD
Orlistat—FASN—Disease—IL17RD—salivary gland cancer	0.00184	0.00325	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL17RD—salivary gland cancer	0.00182	0.00322	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MC3R—salivary gland cancer	0.00179	0.00316	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MC3R—salivary gland cancer	0.00179	0.00316	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PHGDH—salivary gland cancer	0.00177	0.00314	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00172	0.00305	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00172	0.00305	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ST3GAL4—salivary gland cancer	0.00171	0.00302	CbGpPWpGaD
Orlistat—FASN—Disease—MAML3—salivary gland cancer	0.00168	0.00297	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAML3—salivary gland cancer	0.00166	0.00294	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00166	0.00294	CbGpPWpGaD
Orlistat—FASN—Metabolism—MARCKS—salivary gland cancer	0.00166	0.00293	CbGpPWpGaD
Orlistat—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00164	0.0029	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—GUCY1A3—salivary gland cancer	0.00163	0.00288	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—GAS6—salivary gland cancer	0.00163	0.00288	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00158	0.0028	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00158	0.0028	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DTX4—salivary gland cancer	0.00156	0.00277	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DTX4—salivary gland cancer	0.00156	0.00277	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AQP1—salivary gland cancer	0.00155	0.00274	CbGpPWpGaD
Orlistat—FASN—Metabolism—PYGB—salivary gland cancer	0.00154	0.00272	CbGpPWpGaD
Orlistat—PNLIP—Disease—FGF16—salivary gland cancer	0.00153	0.00271	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MC3R—salivary gland cancer	0.00148	0.00262	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.00147	0.00261	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—MAP2K2—salivary gland cancer	0.00147	0.0026	CbGpPWpGaD
Orlistat—PNLIP—Disease—NUP62—salivary gland cancer	0.00147	0.0026	CbGpPWpGaD
Orlistat—PNLIP—Disease—VCAN—salivary gland cancer	0.00146	0.00257	CbGpPWpGaD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—salivary gland cancer	0.00144	0.00255	CbGpPWpGaD
Orlistat—FASN—Disease—ST3GAL4—salivary gland cancer	0.00144	0.00255	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00143	0.00252	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—CREBBP—salivary gland cancer	0.00142	0.00251	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—CREBBP—salivary gland cancer	0.00142	0.00251	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.00142	0.00251	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.00142	0.00251	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00139	0.00245	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00139	0.00245	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAML2—salivary gland cancer	0.00133	0.00235	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00133	0.00235	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.00131	0.00232	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.00131	0.00232	CbGpPWpGaD
Orlistat—FASN—Disease—DTX4—salivary gland cancer	0.00131	0.00232	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DTX4—salivary gland cancer	0.0013	0.00229	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.00129	0.00229	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FGF16—salivary gland cancer	0.00129	0.00229	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FGF16—salivary gland cancer	0.00129	0.00229	CbGpPWpGaD
Orlistat—PLA2G4A—PDGF Pathway—HRAS—salivary gland cancer	0.00129	0.00229	CbGpPWpGaD
Orlistat—FASN—Metabolism—PHGDH—salivary gland cancer	0.00125	0.00222	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NUP62—salivary gland cancer	0.00123	0.00217	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—VCAN—salivary gland cancer	0.00122	0.00216	CbGpPWpGaD
Orlistat—FASN—Metabolism—ST3GAL4—salivary gland cancer	0.00121	0.00214	CbGpPWpGaD
Orlistat—PNLIP—Disease—JAG1—salivary gland cancer	0.00114	0.00201	CbGpPWpGaD
Orlistat—PNLIP—Disease—FGFR4—salivary gland cancer	0.00113	0.002	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAML2—salivary gland cancer	0.00112	0.00199	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAML2—salivary gland cancer	0.00112	0.00199	CbGpPWpGaD
Orlistat—PNLIP—Disease—FBXW7—salivary gland cancer	0.00111	0.00197	CbGpPWpGaD
Orlistat—FASN—Metabolism—AQP1—salivary gland cancer	0.0011	0.00194	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MAP2K2—salivary gland cancer	0.0011	0.00194	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—MAP2K2—salivary gland cancer	0.0011	0.00194	CbGpPWpGaD
Orlistat—FASN—Disease—FGF16—salivary gland cancer	0.00108	0.00192	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FGF16—salivary gland cancer	0.00107	0.0019	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00107	0.00189	CbGpPWpGaD
Orlistat—FASN—Disease—NUP62—salivary gland cancer	0.00104	0.00184	CbGpPWpGaD
Orlistat—FASN—Disease—VCAN—salivary gland cancer	0.00103	0.00182	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—salivary gland cancer	0.000977	0.00173	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MYB—salivary gland cancer	0.000969	0.00171	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—EP300—salivary gland cancer	0.000966	0.00171	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—EP300—salivary gland cancer	0.000966	0.00171	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—JAG1—salivary gland cancer	0.000959	0.0017	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—JAG1—salivary gland cancer	0.000959	0.0017	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FGFR4—salivary gland cancer	0.000955	0.00169	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FGFR4—salivary gland cancer	0.000955	0.00169	CbGpPWpGaD
Orlistat—FASN—Disease—MAML2—salivary gland cancer	0.000941	0.00166	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FBXW7—salivary gland cancer	0.00094	0.00166	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FBXW7—salivary gland cancer	0.00094	0.00166	CbGpPWpGaD
Orlistat—PNLIP—Disease—FOXO3—salivary gland cancer	0.000938	0.00166	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAML2—salivary gland cancer	0.000931	0.00165	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—salivary gland cancer	0.000904	0.0016	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000895	0.00158	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—HRAS—salivary gland cancer	0.000881	0.00156	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ISYNA1—salivary gland cancer	0.000871	0.00154	CbGpPWpGaD
Orlistat—FASN—Metabolism—NUP62—salivary gland cancer	0.00087	0.00154	CbGpPWpGaD
Orlistat—FASN—Metabolism—VCAN—salivary gland cancer	0.000863	0.00153	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000857	0.00152	CbGpPWpGaD
Orlistat—FASN—Disease—JAG1—salivary gland cancer	0.000803	0.00142	CbGpPWpGaD
Orlistat—FASN—Disease—FGFR4—salivary gland cancer	0.0008	0.00141	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—JAG1—salivary gland cancer	0.000795	0.00141	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FOXO3—salivary gland cancer	0.000793	0.0014	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FOXO3—salivary gland cancer	0.000793	0.0014	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FGFR4—salivary gland cancer	0.000792	0.0014	CbGpPWpGaD
Orlistat—FASN—Disease—FBXW7—salivary gland cancer	0.000787	0.00139	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—PTEN—salivary gland cancer	0.00078	0.00138	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FBXW7—salivary gland cancer	0.000779	0.00138	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000778	0.00138	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAP2K2—salivary gland cancer	0.000766	0.00135	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000764	0.00135	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MC3R—salivary gland cancer	0.000762	0.00135	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000757	0.00134	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000729	0.00129	CbGpPWpGaD
Orlistat—PLA2G4A—Phospholipid metabolism—PTEN—salivary gland cancer	0.000721	0.00127	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—PIK3CA—salivary gland cancer	0.000715	0.00126	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—PIK3CA—salivary gland cancer	0.000715	0.00126	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MARCKS—salivary gland cancer	0.00071	0.00126	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—salivary gland cancer	0.000691	0.00122	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—salivary gland cancer	0.000691	0.00122	CbGpPWpGaD
Orlistat—FASN—Disease—FOXO3—salivary gland cancer	0.000664	0.00117	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HRAS—salivary gland cancer	0.000661	0.00117	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—HRAS—salivary gland cancer	0.000661	0.00117	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PYGB—salivary gland cancer	0.00066	0.00117	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FOXO3—salivary gland cancer	0.000657	0.00116	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAP2K2—salivary gland cancer	0.000647	0.00114	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAP2K2—salivary gland cancer	0.000647	0.00114	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOTCH1—salivary gland cancer	0.000628	0.00111	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000576	0.00102	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—WNT5B—salivary gland cancer	0.000572	0.00101	CbGpPWpGaD
Orlistat—PNLIP—Disease—CREBBP—salivary gland cancer	0.000569	0.00101	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000556	0.000983	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL17RD—salivary gland cancer	0.000552	0.000976	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—salivary gland cancer	0.00055	0.000973	CbGpPWpGaD
Orlistat—FASN—Disease—MAP2K2—salivary gland cancer	0.000542	0.000958	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000541	0.000956	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000539	0.000953	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PHGDH—salivary gland cancer	0.000538	0.000952	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAP2K2—salivary gland cancer	0.000536	0.000949	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOTCH1—salivary gland cancer	0.00053	0.000938	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOTCH1—salivary gland cancer	0.00053	0.000938	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00053	0.000937	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ST3GAL4—salivary gland cancer	0.000518	0.000916	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000516	0.000912	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—HRAS—salivary gland cancer	0.000509	0.0009	CbGpPWpGaD
Orlistat—PLA2G4A—Phospholipid metabolism—PIK3CA—salivary gland cancer	0.000508	0.000899	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAML3—salivary gland cancer	0.000505	0.000893	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CREBBP—salivary gland cancer	0.000481	0.00085	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CREBBP—salivary gland cancer	0.000481	0.00085	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CREBBP—salivary gland cancer	0.000477	0.000843	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AQP1—salivary gland cancer	0.000471	0.000832	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000452	0.000799	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000452	0.000799	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MC3R—salivary gland cancer	0.00045	0.000796	CbGpPWpGaD
Orlistat—FASN—Disease—NOTCH1—salivary gland cancer	0.000444	0.000785	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOTCH1—salivary gland cancer	0.00044	0.000777	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000433	0.000766	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00041	0.000725	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00041	0.000725	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTEN—salivary gland cancer	0.000406	0.000719	CbGpPWpGaD
Orlistat—FASN—Disease—CREBBP—salivary gland cancer	0.000403	0.000712	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CREBBP—salivary gland cancer	0.000399	0.000705	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DTX4—salivary gland cancer	0.000393	0.000696	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000392	0.000693	CbGpPWpGaD
Orlistat—PNLIP—Disease—EP300—salivary gland cancer	0.000388	0.000685	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000381	0.000675	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HRAS—salivary gland cancer	0.000379	0.000671	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HRAS—salivary gland cancer	0.000379	0.000671	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000379	0.000671	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NUP62—salivary gland cancer	0.000373	0.00066	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—VCAN—salivary gland cancer	0.00037	0.000655	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CREBBP—salivary gland cancer	0.000357	0.000631	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCND1—salivary gland cancer	0.000356	0.000629	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCND1—salivary gland cancer	0.000356	0.000629	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000349	0.000617	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTEN—salivary gland cancer	0.000343	0.000607	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PTEN—salivary gland cancer	0.000343	0.000607	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTEN—salivary gland cancer	0.00034	0.000602	CbGpPWpGaD
Orlistat—FASN—Metabolism—CREBBP—salivary gland cancer	0.000337	0.000596	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EP300—salivary gland cancer	0.000328	0.000579	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EP300—salivary gland cancer	0.000328	0.000579	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGF16—salivary gland cancer	0.000325	0.000575	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000325	0.000575	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—EP300—salivary gland cancer	0.000325	0.000574	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCND1—salivary gland cancer	0.000295	0.000521	CbGpPWpGaD
Orlistat—FASN—Disease—PTEN—salivary gland cancer	0.000288	0.000508	CbGpPWpGaD
Orlistat—PNLIP—Disease—PIK3CA—salivary gland cancer	0.000287	0.000507	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PTEN—salivary gland cancer	0.000285	0.000503	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAML2—salivary gland cancer	0.000283	0.0005	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000276	0.000488	CbGpPWpGaD
Orlistat—FASN—Disease—EP300—salivary gland cancer	0.000274	0.000485	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EP300—salivary gland cancer	0.000271	0.00048	CbGpPWpGaD
Orlistat—PNLIP—Disease—HRAS—salivary gland cancer	0.000265	0.000469	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EP300—salivary gland cancer	0.000243	0.00043	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CA—salivary gland cancer	0.000242	0.000428	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CA—salivary gland cancer	0.000242	0.000428	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JAG1—salivary gland cancer	0.000241	0.000427	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTEN—salivary gland cancer	0.000241	0.000426	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGFR4—salivary gland cancer	0.00024	0.000425	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CA—salivary gland cancer	0.00024	0.000425	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FBXW7—salivary gland cancer	0.000236	0.000418	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—salivary gland cancer	0.000234	0.000414	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—salivary gland cancer	0.000234	0.000414	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000232	0.00041	CbGpPWpGaD
Orlistat—FASN—Metabolism—EP300—salivary gland cancer	0.00023	0.000406	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HRAS—salivary gland cancer	0.000224	0.000396	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HRAS—salivary gland cancer	0.000224	0.000396	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000221	0.000391	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000204	0.000361	CbGpPWpGaD
Orlistat—FASN—Disease—PIK3CA—salivary gland cancer	0.000203	0.000359	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CA—salivary gland cancer	0.000201	0.000355	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FOXO3—salivary gland cancer	0.000199	0.000353	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—salivary gland cancer	0.000194	0.000343	CbGpPWpGaD
Orlistat—FASN—Disease—HRAS—salivary gland cancer	0.000188	0.000332	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HRAS—salivary gland cancer	0.000186	0.000328	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CA—salivary gland cancer	0.00018	0.000318	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—salivary gland cancer	0.000174	0.000308	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CA—salivary gland cancer	0.00017	0.0003	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000166	0.000294	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HRAS—salivary gland cancer	0.000166	0.000294	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000164	0.000289	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000163	0.000288	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000155	0.000273	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CREBBP—salivary gland cancer	0.000145	0.000256	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000133	0.000236	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000126	0.000223	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000121	0.000215	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CREBBP—salivary gland cancer	0.000121	0.000214	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.00011	0.000195	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTEN—salivary gland cancer	0.000103	0.000183	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000103	0.000182	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EP300—salivary gland cancer	9.85e-05	0.000174	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HRAS—salivary gland cancer	9.55e-05	0.000169	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCND1—salivary gland cancer	8.95e-05	0.000158	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NUP62—salivary gland cancer	8.74e-05	0.000155	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—VCAN—salivary gland cancer	8.67e-05	0.000153	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTEN—salivary gland cancer	8.64e-05	0.000153	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EP300—salivary gland cancer	8.24e-05	0.000146	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CA—salivary gland cancer	7.29e-05	0.000129	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CA—salivary gland cancer	6.1e-05	0.000108	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—salivary gland cancer	5.9e-05	0.000104	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HRAS—salivary gland cancer	5.64e-05	9.97e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.39e-05	5.99e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.42e-05	4.28e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EP300—salivary gland cancer	2.31e-05	4.08e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.71e-05	3.02e-05	CbGpPWpGaD
